Antiretroviral therapy coverage for PMTCT in Burkina Faso
Burkina Faso: Antiretroviral therapy coverage for PMTCT was 69.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Burkina Faso, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage for pmtct in Burkina Faso is 69.0%, measured in 2024.
Compared with earlier readings it is down 5.5% on the previous year and up 11.3% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Burkina Faso peaked at 90.0% in 2022 and was at its lowest, 0.0%, in 2000.
Burkina Faso ranks 52nd of 84 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Burkina Faso, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 1.0% | — |
| 2004 | 3.0% | +200.0% |
| 2005 | 9.0% | +200.0% |
| 2006 | 19.0% | +111.1% |
| 2007 | 19.0% | +0.0% |
| 2008 | 18.0% | -5.3% |
| 2009 | 31.0% | +72.2% |
| 2010 | 37.0% | +19.4% |
| 2011 | 42.0% | +13.5% |
| 2012 | 44.0% | +4.8% |
| 2013 | 47.0% | +6.8% |
| 2014 | 62.0% | +31.9% |
| 2015 | 44.0% | -29.0% |
| 2016 | 50.0% | +13.6% |
| 2017 | 55.0% | +10.0% |
| 2018 | 63.0% | +14.5% |
| 2019 | 71.0% | +12.7% |
| 2020 | 80.0% | +12.7% |
| 2021 | 87.0% | +8.8% |
| 2022 | 90.0% | +3.4% |
| 2023 | 73.0% | -18.9% |
| 2024 | 69.0% | -5.5% |
Burkina Faso compared with similar countries
- Burkina Faso's 69.0% is below the median for low income countries, which is 73.0%, 95% of the median. (22 countries reporting)
- Burkina Faso's 69.0% is below the median for Sub-Saharan Africa, which is 82.0%, 84% of the median. (41 countries reporting)
Biggest year-on-year movements
Years where Antiretroviral therapy coverage for PMTCT in Burkina Faso changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2004 | +200.0% | 1.0% | 3.0% |
| 2005 | +200.0% | 3.0% | 9.0% |
| 2006 | +111.1% | 9.0% | 19.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 10.0% | 0.0% | 31.0% | 10 |
| 2010s | 51.5% | 37.0% | 71.0% | 10 |
| 2020s | 79.8% | 69.0% | 90.0% | 5 |
Countries ranked near Burkina Faso
More health data for Burkina Faso
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8925 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,142 deaths per 1,000 people (2090)
- Number of infants who die before age 1 13,085 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 4 (2025)
- Population ages 00-04, female, annual growth rate 0.8681 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0693 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.7133 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Burkina Faso?
- Antiretroviral therapy coverage for pmtct in Burkina Faso was 69.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Burkina Faso?
- The highest recorded value was 90.0% in 2022.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Burkina Faso?
- The lowest recorded value was 0.0% in 2000.
- How does Burkina Faso rank for antiretroviral therapy coverage for pmtct?
- Burkina Faso ranks 52nd out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Burkina Faso?
- Over the last ten years it is up 11.3%. The long-run trend across the full record is volatile.
- Where does this Burkina Faso data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).